• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西班牙巴伦西亚社区的基层医疗中心接受治疗的患者中,带状疱疹感染的流行病学。

Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).

机构信息

Centro Superior de Investigaciones en Salud Pública de Valencia (CSISP), Av, Cataluña 21, 46020, Valencia, Spain.

出版信息

BMC Fam Pract. 2010 May 6;11:33. doi: 10.1186/1471-2296-11-33.

DOI:10.1186/1471-2296-11-33
PMID:20459608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2874789/
Abstract

BACKGROUND

There is little available data regarding the epidemiology of herpes zoster (HZ) in Spain. This study's main goal was to estimate the annual incidence of HZ in the Autonomous Community of Valencia.

METHODS

From December 1st 2006 to December 1st 2007, a prospective study was carried out in 24 primary health care centres that together provide care for a population of 36,030 persons aged >14 years. We included all adult patients with a clinical diagnosis of HZ who were seen at these centres during the one-year study period. Demographic (i.e., age, gender, and area of residence) and clinical data were also collected from these patients.

RESULTS

A total of 146 cases of HZ were identified during the study period. The annual incidence of HZ was 4.1/1,000 individuals >14 years of age (95% confidence interval [CI]: 3.4-4.7). Cases of HZ were predominantly unilateral and most commonly affected women and people living in rural areas. The most frequently reported symptoms were pain, dysesthesia and itching. A total of 46% of patients also had underlying illnesses (e.g., chronic diseases and/or malignancy) and 24% of patients experienced complications, which were mostly ocular in nature. A total of 91% of patients were treated with antiviral drugs. The median time from symptoms onset to diagnosis was 6.3 days (range: 2.0-8.3).

CONCLUSIONS

HZ is a common illness in our region (especially in the older population) that causes a significant clinical burden on primary care providers.

摘要

背景

西班牙带状疱疹(HZ)的流行病学数据很少。本研究的主要目的是估计巴伦西亚自治区的 HZ 年发病率。

方法

2006 年 12 月 1 日至 2007 年 12 月 1 日,对 24 个初级保健中心进行了前瞻性研究,这些中心共同为 36030 名> 14 岁的人群提供服务。我们纳入了在这一年的研究期间在这些中心就诊的患有 HZ 临床诊断的所有成年患者。还从这些患者中收集了人口统计学(即年龄、性别和居住地区)和临床数据。

结果

在研究期间共发现 146 例 HZ。HZ 的年发病率为 14 岁以上人群 4.1/1000 人(95%置信区间 [CI]:3.4-4.7)。HZ 病例主要为单侧,最常见的是女性和居住在农村地区的人。最常见的症状是疼痛、感觉异常和瘙痒。共有 46%的患者有基础疾病(如慢性病和/或恶性肿瘤),24%的患者出现并发症,主要是眼部并发症。共有 91%的患者接受了抗病毒药物治疗。从症状出现到诊断的中位时间为 6.3 天(范围:2.0-8.3)。

结论

HZ 在我们地区是一种常见疾病(尤其是在老年人群中),对初级保健提供者造成了重大的临床负担。

相似文献

1
Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).在西班牙巴伦西亚社区的基层医疗中心接受治疗的患者中,带状疱疹感染的流行病学。
BMC Fam Pract. 2010 May 6;11:33. doi: 10.1186/1471-2296-11-33.
2
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.在西班牙巴伦西亚社区的基层医疗中心治疗的患者中,带状疱疹和带状疱疹后神经痛的流行病学和费用。
BMC Infect Dis. 2011 Nov 1;11:302. doi: 10.1186/1471-2334-11-302.
3
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).社会人口学特征和慢性疾病作为带状疱疹的危险因素:一项来自西班牙马德里初级保健机构的基于人群的研究
Hum Vaccin Immunother. 2014;10(6):1650-60. doi: 10.4161/hv.28620. Epub 2014 May 7.
4
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).在西班牙巴伦西亚自治区使用电子数据库进行带状疱疹监测。
BMC Infect Dis. 2013 Oct 5;13:463. doi: 10.1186/1471-2334-13-463.
5
Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014.慢性阻塞性肺疾病(COPD)患者带状疱疹的风险和影响:一项基于人群的研究,2009-2014 年。
BMC Infect Dis. 2018 May 3;18(1):203. doi: 10.1186/s12879-018-3121-x.
6
Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009-2014.免疫功能低下人群的带状疱疹风险和疾病负担:基于人群的研究,使用健康系统综合数据库,2009-2014 年。
BMC Infect Dis. 2020 Nov 30;20(1):905. doi: 10.1186/s12879-020-05648-6.
7
Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.丹麦带状疱疹疫苗接种前的流行病学:发病率及风险因素的量化分析
Vaccine. 2017 Oct 9;35(42):5589-5596. doi: 10.1016/j.vaccine.2017.08.065. Epub 2017 Sep 2.
8
Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003-2013.2003-2013 年马德里(西班牙)带状疱疹相关住院治疗的时间趋势。
J Infect. 2015 Jul;71(1):85-92. doi: 10.1016/j.jinf.2015.01.015. Epub 2015 Mar 3.
9
The Prevalence and Risk for Herpes Zoster Infection in Adult Patients With Diabetes Mellitus in the Canadian Primary Care Sentinel Surveillance Network.加拿大初级保健监测网络中成年糖尿病患者带状疱疹感染的流行率和风险。
Can J Diabetes. 2018 Oct;42(5):465-469. doi: 10.1016/j.jcjd.2017.10.060. Epub 2017 Nov 20.
10
Annual incidence rates of herpes zoster among an immunocompetent population in the United States.美国免疫功能正常人群中带状疱疹的年发病率。
BMC Infect Dis. 2015 Nov 6;15:502. doi: 10.1186/s12879-015-1262-8.

引用本文的文献

1
The Incidence of Herpes Zoster Complications: A Systematic Literature Review.带状疱疹并发症的发病率:一项系统文献综述。
Infect Dis Ther. 2024 Jul;13(7):1461-1486. doi: 10.1007/s40121-024-01002-4. Epub 2024 Jun 19.
2
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.全球带状疱疹发病率、疾病负担及疫苗可及性:一项叙述性综述
Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022.
3
A systematic literature review of herpes zoster incidence worldwide.一项关于全球带状疱疹发病率的系统文献综述。
Hum Vaccin Immunother. 2021 Jun 3;17(6):1714-1732. doi: 10.1080/21645515.2020.1847582. Epub 2021 Mar 2.
4
Risk Factors for Herpes Zoster Infection: A Meta-Analysis.带状疱疹感染的危险因素:一项荟萃分析。
Open Forum Infect Dis. 2020 Jan 9;7(1):ofaa005. doi: 10.1093/ofid/ofaa005. eCollection 2020 Jan.
5
Balanitis is a risk factor for herpes zoster.龟头炎是带状疱疹的一个危险因素。
Eur J Clin Microbiol Infect Dis. 2015 May;34(5):985-90. doi: 10.1007/s10096-015-2314-0. Epub 2015 Jan 18.
6
Herpes zoster and postherpetic neuralgia in Catalonia (Spain).西班牙加泰罗尼亚地区的带状疱疹及带状疱疹后神经痛
Hum Vaccin Immunother. 2015;11(1):178-84. doi: 10.4161/hv.34421. Epub 2014 Nov 1.
7
Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study.意大利50岁及以上患者带状疱疹相关性慢性疼痛负担(2009 - 2010年):一项基于全科医生的前瞻性队列研究。
BMC Infect Dis. 2014 Dec 6;14:637. doi: 10.1186/s12879-014-0637-6.
8
Systematic review of incidence and complications of herpes zoster: towards a global perspective.带状疱疹发病率及并发症的系统评价:全球视角
BMJ Open. 2014 Jun 10;4(6):e004833. doi: 10.1136/bmjopen-2014-004833.
9
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).社会人口学特征和慢性疾病作为带状疱疹的危险因素:一项来自西班牙马德里初级保健机构的基于人群的研究
Hum Vaccin Immunother. 2014;10(6):1650-60. doi: 10.4161/hv.28620. Epub 2014 May 7.
10
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).在西班牙巴伦西亚自治区使用电子数据库进行带状疱疹监测。
BMC Infect Dis. 2013 Oct 5;13:463. doi: 10.1186/1471-2334-13-463.

本文引用的文献

1
Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination.带状疱疹与水痘带状疱疹病毒暴露在水痘疫苗时代。
Am J Public Health. 2010 Jun;100(6):1116-22. doi: 10.2105/AJPH.2009.160002. Epub 2010 Jan 14.
2
Impact of varicella vaccine on varicella-zoster virus dynamics.水痘疫苗对水痘-带状疱疹病毒动力学的影响。
Clin Microbiol Rev. 2010 Jan;23(1):202-17. doi: 10.1128/CMR.00031-09.
3
Neuropathic pain and its assessment.神经病理性疼痛及其评估。
Surg Oncol. 2010 Sep;19(3):149-54. doi: 10.1016/j.suronc.2009.11.012. Epub 2010 Jan 6.
4
Antiviral treatment for preventing postherpetic neuralgia.预防带状疱疹后神经痛的抗病毒治疗。
Cochrane Database Syst Rev. 2009 Apr 15(2):CD006866. doi: 10.1002/14651858.CD006866.pub2.
5
[Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006].[2005 - 2006年纳瓦拉地区在儿童系统性疫苗接种引入之前的水痘和带状疱疹发病率]
An Sist Sanit Navar. 2008 Jan-Apr;31(1):71-80. doi: 10.4321/s1137-66272008000100006.
6
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.英国带状疱疹及带状疱疹后神经痛的流行病学与成本
Epidemiol Infect. 2009 Jan;137(1):38-47. doi: 10.1017/S0950268808000678. Epub 2008 May 9.
7
A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.一项在引入带状疱疹疫苗之前基于人群的带状疱疹发病率和并发症发生率研究。
Mayo Clin Proc. 2007 Nov;82(11):1341-9. doi: 10.4065/82.11.1341.
8
Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.基于哨兵全科医生网络的马德里水痘和带状疱疹情况:1997 - 2004年
BMC Infect Dis. 2007 Jun 15;7:59. doi: 10.1186/1471-2334-7-59.
9
Recommendations for the management of herpes zoster.带状疱疹管理建议。
Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26. doi: 10.1086/510206.
10
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.荷兰水痘和带状疱疹的流行病学:对水痘带状疱疹病毒疫苗接种的影响。
Vaccine. 2006 May 1;24(18):3946-52. doi: 10.1016/j.vaccine.2006.02.017. Epub 2006 Feb 24.